Cardiovascular Disease, Sudden Cardiac Death, and Preparticipation Screening in Young Competitive Athletes

Pediatric Cardiovascular Medicine: Second Edition

Volumn , Issue , 2012, Pages 814-825

  Maron, Barry J ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

Athletes; Cardiomyopathy; Electrocardiography; Hypertrophic cardiomyopathy; Physical activity; Population screening; Sudden death

Indexed keywords

EID: 84885544413     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444398786.ch57     Document Type: Chapter

References (85)

1. Maron BJ. Sudden death in young athletes: lessons from the Hank Gathers affair. N Engl J Med 1993;329:55-7.
2. Maron BJ, Mitten MJ, Quandt EK, Zipes DP. Competitive athletes with cardiovascular disease - the case of Nicholas Knapp. N Engl J Med 1998;339:1632-5.
3. Maron BJ, Zipes DP. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol 2005;45:1312-75.
4. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remod eling and the risks of sports including sudden death. Circulation 2006;114:1633-44.
5. Maron BJ. Sudden death in young athletes. N Engl J Med 2003;349:1064-75.
6. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med 1998;129:379-86.
7. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes: a statement for health professionals from the Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular Diseases in the Young), American Heart Association. Circulation 1996;94:850-6.
8. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: update 2007. A Scientific Statement from the American Heart Association, Nutrition, Physical Activity, and Metabolism Council. Circulation 2007;115:1643-55.
9. Baggish AL, Hutter AM Jr, Wang F, et al. Addition of 12-lead electrocardiography to medical history and physical examination for cardiovascular screening in college athletes. A cross-sectional study. Ann Intern Med 2010;152:269-75.
10. Wheeler, MT, Heidenreich PA, Froelicher VF, et al. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med 2010;152:276-86.
11. Pelliccia A, Fagard, Bjornstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document for the European Society of Cardiology. Eur Heart J 2005;26:1422-45.
12. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296: 1593-601.
13. Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:510-24.
14. Myerburg RJ, Vetter LV. Electrocardiograms should be included in preparticipation screening of athletes. Circulation 2007; 116:2616-26.
15. Chaitman BR. An electrocardiogram should not be included in routine preparticipation screening of young athletes. Circulation 2007;116:2610-4.
16. Pelliccia A, DiPaolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 2008;358:152-61.
17. Basavarajaiah S, Wilson M, Whyte G, et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes. Relevance to pre-participation screening. J Am Coll Cardiol 2008;51:1033-9.
18. Corrado D, Basso C, Schiaron M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-9.
19. Van Camp SP, Bloor CM, Mueller FO, et al. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 1995;27:641-7.
20. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes: clinical, demographic and pathological profiles. JAMA 1996;276:199-204.
21. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1,866 deaths in the U.S., 1980-2006. Circulation 2009;119:1085-92.
22. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41:974-80.
23. Maron BJ, Haas TS, Doerer JJ, et al. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 2009;104:276-80.
24. Maron BJ, Gohman TE, Kyle SB, et al. Clinical profile and spectrum of commotio cordis. JAMA 2002;287:1142-6.
25. Maron BJ, Poliac L, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 1995;333:337-42.
26. Maron BJ, Estes NAM III. Commotio cordis. N Engl J Med 2010;362:917-27.
27. Bille K, Figueiras D, Schamasch P, et al. Sudden cardiac death in athletes: the Lausanne recommendations. Eur J Cardiovasc Prev Rehabil 2006;13:859-75.
28. Maron BJ. National electrocardiography screening for competitive athletes: feasible in the United States?. (Editorial) Ann Intern Med 2010;152:324-6.
29. Glover DW, Maron BJ. Profile of preparticipation cardiovascular screening for high school athletes. JAMA 1998;279:1817-9.
30. Glover DW, Glover DW, Maron BJ. Evolution in the process of screening United States high school student-athletes for cardiovascular disease. Am J Cardiol 2007;100:1709-12.
31. Thompson PD, Levin BD. Protecting athletes from sudden cardiac death (Editorial). JAMA 2006;296:1648-50.
32. Lewis JF, Maron BJ, Diggs JA, et al. Preparticipation echocardiographic screening for cardiovascular disease in a large predominantly black population of collegiate athletes. Am J Cardiol 1989;64:1029-33.
33. Marek JC, Pelliccia A, Corrado D, Maron BJ. Electrocardiography and preparticipation screening of competitive high school athletes. Ann Intern Med 2010;153:131-3.
34. Maron BJ. Diversity of views from Europe on national preparticipation screening for competitive athletes. Heart Rhythm 2010;7:1372-3.
35. Maron BJ, Douglas PS, Graham TP, et al. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol 2005;45:1322-6.
36. Lawless CE, Best TM. Electrocardiograms in athletes: interpretation and diagnostic accuracy. Med Sci Sports Exerc 2008;40:787-98.
37. Bessem B, Groot FP, Nieuwland W. The Lausanne recommendations: a Dutch experience. Br J Sports Med 2009;43:708-15.
38. Le VV, Wheeler MT, Mandic S, et al. Addition of the electrocardiogram to the preparticipation examination of college athletes. Clin J Sport Med 2010;20:98-105.
39. Ma JZ, Dai J, Sun B, et al. Cardiovascular pre-participation screen ing of young competitive athletes for prevention of sudden death in China. J Sci Med Sport 2007;10:227-33.
40. Harris KM, Sponsel A, Hutter AM Jr, Maron BJ. Cardiovascular screening practices of major North American professional sports teams. Ann Intern Med 2006;145:507-11.
41. Maron BJ, Zipes DP. Introduction. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities - General Considerations. J Am Coll Cardiol 2005;45:1318-21.
42. Maron BJ, Chaitman B, Ackerman MJ, et al. American Heart Association Scientific Statement: Recommendations for Physical Activity and Recreational Sports Participation for Young Patients with Genetic Cardiovascular Diseases. Circulation 2004;109:2807-16.
43. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995;91:1596-601.
44. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiologic remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening. Br J Sports Med 2009;43:649-56.
45. Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes. Relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol 2008;51:2256-62.
46. Sharma S, Maron BJ, Whyte G, et al. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:1431-6.
47. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observation and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-708.
48. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20.
49. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003; 42:1687-713.
50. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy from bench to the clinics. J Cardiovasc Electrophysiol 2008;19:104-10.
51. Maron BJ, Gardin JM, Flack JM, et al. Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995;92:785-9.
52. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006;114:2232-9.
53. Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54:220-8.
54. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2002;35:1493-501.
55. Knickelbine T, Lesser RJ, Brandenburg ER, et al. Identification of unexpected nonatherosclerotic cardiovascular disease with CT angiography. J Am Coll Cardiol Img 2009;2:1085-92.
56. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
57. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30 year Italian experience. Am J Cardiol 1995;75:827-9.
58. Basso C, Thiene G, Mackey-Bojack S, et al. Myocardial bridging: a frequent component of the hypertrophic cardiomyopathy phenotype lacks systematic association with sudden cardiac death. Eur Heart J 2009;30:1627-34.
59. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 2010;121:445-56.
60. Kloner RA, Hale S, Alkekr K, Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation 1992;85:407-19.
61. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998;32:1881-4.
62. Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol 1996;28:428-31.
63. Roberts WO, Maron BJ. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol 2005;46:1373-4.
64. Maron BJ, Kogan J, Proschan MA, et al. Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1994;23:1405-9.
65. Estes NA III, Link MS, Cannon D, et al. Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol 2001;12:1208-19.
66. Drezner JA, Courson RW, Roberts WO, et al.; Inter-Association Task Force. Inter-Association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Heart Rhythm 2007;4:549-65.
67. Drezner JA. Preparing for sudden cardiac arrest - the essential role of automated external defibrillators in athletic medicine: a critical review. Br J Sports Med 2009;43:702-7.
68. Rothmier JD, Drezner JA, Harmon KG. Automated external defibrillators in Washington State high schools. Br J Sports Med 2007;41:301-5.
69. Drezner JA, Rogers KJ, Zimmer RR, Sennett BJ. Use of automatied external defibrillators at NCAA Division I universities. Med Sci Sports Exerc 2005;37:1487-92.
70. Drezner JA, Rao AL, Heistand J, et al. Effectiveness of emergency response planning for sudden cardiac arrest in United States high schools with automated external defibrillators. Circulation 2009;120:518-25.
71. Mitten MJ, Maron BJ, Zipes DP. Task Force 12: legal aspects of the 36th Bethesda Conference Recommendations. 36th Bethesda Conference Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol 2005;45:1373-5.
72. Paterick TE, Paterick TJ, Fletcher GF, Maron BJ. Medical and legal issues impacting the cardiovascular evaluation of competitive athletes. JAMA 2005;294:3011-8. 825
73. Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol 2006;98:1507-11.
74. Wilson MG, Basavarajaiah S, Whyte GP, et al. Efficacy of personal symptoms and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med 2008;42:207-11.
75. Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010;31:243-59.
76. Montgomery JV, Harris KM, Casey SA, et al. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;96:270-5.
77. Maron BJ, Niimura H, Casey SA, et al. Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C mutations. J Am Coll Cardiol 2001;38:315-21.
78. McLeod CL, Ackerman MJ, Nishimura RA, et al. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol 2009;54:229-33.
79. Wren C. Screening for potentially fatal heart disease in children and teenagers. Heart 2009;95:2040-6.
80. Chaitman BR, Fromer M. Should ECG be required in young athletes?. Lancet 2008;371:1489-90.
81. Culasso F, Di Paolo FM, Spataro A, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-84.
82. Maron BJ, Bodison S, Wesley Y, et al. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol 1987;10:1214-21.
83. Magalski A, Maron BJ, Main ML, et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol 2008;51:2250-5.
84. Corrado D, Basso C, Schiavon M, et al. Preparticipation screening of young competitive athletes. J Am Coll Cardiol 2008;52: 1981-8.
85. Holst AG, Winkel BG, Theilade J, et al. Incidence and etiology of sports-related sudden cardiac death in Denmark - implications for preparticipation screening. Heart Rhythm 2010; 7:1365-71.